Physician profile
Patrick P Pedro
NPI 1093915068
$14,412.56
in general payments reported to CMS, 2019-2025
10 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.00 · 2020: $8,413 · 2021: $32.81 · 2022: $2,089 · 2023: $363 · 2024: $2,371 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,953 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,953.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $876.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,643.70 | 2020-2025 | |
| Abbvie INC. | $182.93 | 2021-2024 | |
| Medtronic, INC. | $175.85 | 2023 | Signia |
| Smith+Nephew, INC. | $158.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $83.49 | 2022-2023 | Andexxa |
| Kci USA, INC. | $72.73 | 2023 | Abthera Advance |
| Allergan, INC. | $38.17 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $30.86 | 2020-2021 | |
| Heron Therapeutics, INC. | $15.12 | 2022 | |
| Pfizer INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Pedro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.